DAA2308 |
chemokine (C-X3-C motif) ligand 1 decreases with age |
Molecular |
frontal lobe |
Human |
CX3CL1 |
58.0% Decrease Gene Expression Level |
|
DAA2236 |
CD14 molecule increases with age |
Molecular |
frontal lobe |
Human |
CD14 |
134.9% Increase Gene Expression Level |
|
DAA2325 |
major histocompatibility complex, class II, DP alpha 1 increases with age |
Molecular |
frontal lobe |
Human |
HLA-DPA1 |
97.1% Increase Gene Expression Level |
|
DAA2342 |
major histocompatibility complex, class I, C increases with age |
Molecular |
frontal lobe |
Human |
HLA-C |
40.1% Increase Gene Expression Level |
|
DAA2240 |
toll-like receptor 4 increases with age |
Molecular |
frontal lobe |
Human |
TLR4 |
83.7% Increase Gene Expression Level |
|
DAA2382 |
major histocompatibility complex, class I, C increases with age |
Molecular |
frontal lobe |
Human |
HLA-C |
44.0% Increase Gene Expression Level |
|
DAA2379 |
major histocompatibility complex, class I, B increases with age |
Molecular |
frontal lobe |
Human |
HLA-B |
39.0% Increase Gene Expression Level |
|
DAA2288 |
CD163 molecule increases with age |
Molecular |
frontal lobe |
Human |
CD163 |
383.1% Increase Gene Expression Level |
|
DAA2368 |
major histocompatibility complex, class II, DP beta 1 increases with age |
Molecular |
frontal lobe |
Human |
HLA-DPB1 |
76.9% Increase Gene Expression Level |
|
DAA2341 |
major histocompatibility complex, class I, B increases with age |
Molecular |
frontal lobe |
Human |
HLA-B |
36.5% Increase Gene Expression Level |
|
DAA2235 |
toll interacting protein decreases with age |
Molecular |
frontal lobe |
Human |
TOLLIP |
36.3% Decrease Gene Expression Level |
|
DAA2347 |
HLA-G histocompatibility antigen, class I, G increases with age |
Molecular |
frontal lobe |
Human |
HLA-G |
28.4% Increase Gene Expression Level |
|
DAA2294 |
Fc fragment of IgG, receptor, transporter, alpha increases with age |
Molecular |
frontal lobe |
Human |
FCGRT |
89.3% Increase Gene Expression Level |
|
DAA2293 |
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) increases with age |
Molecular |
frontal lobe |
Human |
FCGR3B |
52.1% Increase Gene Expression Level |
|
DAA2233 |
toll interacting protein decreases with age |
Molecular |
frontal lobe |
Human |
TOLLIP |
59.5% Decrease Gene Expression Level |
|
DAA2162 |
Fc fragment of IgG, low affinity IIIb, receptor (CD16b) increases with age |
Molecular |
frontal lobe |
Human |
FCGR3B |
261.1% Increase Gene Expression Level |
|
DAA2292 |
Fc fragment of IgG, low affinity IIa, receptor (CD32) increases with age |
Molecular |
frontal lobe |
Human |
FCGR2A |
104.3% Increase Gene Expression Level |
|
DAA2326 |
major histocompatibility complex, class II, DR alpha increases with age |
Molecular |
frontal lobe |
Human |
HLA-DRA |
146.8% Increase Gene Expression Level |
|
DAA2145 |
Fc fragment of IgG, high affinity Ib, receptor (CD64) increases with age |
Molecular |
frontal lobe |
Human |
FCGR1B |
170.4% Increase Gene Expression Level |
|
DAA2234 |
toll interacting protein decreases with age |
Molecular |
frontal lobe |
Human |
TOLLIP |
57.8% Decrease Gene Expression Level |
|
DAA2369 |
major histocompatibility complex, class II, DR alpha increases with age |
Molecular |
frontal lobe |
Human |
HLA-DRA |
135.3% Increase Gene Expression Level |
|
DAA2144 |
Fc fragment of IgG, high affinity Ia, receptor (CD64) increases with age |
Molecular |
frontal lobe |
Human |
FCGR1A |
157.3% Increase Gene Expression Level |
|
DAA2137 |
major histocompatibility complex, class II, DR beta 1 increases with age |
Molecular |
frontal lobe |
Human |
HLA-DRB1 |
83.0% Increase Gene Expression Level |
|